Abstract:Background Chemotherapy is a widely used treatment for cancer. However, the development of acquired multidrug resistance (MDR) is a serious issue. Emerging evidence has shown that the extracellular vesicles (EVs) mediate MDR, but the underlying mechanism remains unclear, especially the effects of chemotherapeutic agents on this process. Methods Extracellular vesicles isolation was performed by differential centrifugation. The recipient cells that acquired ATP-binding cassette sub-family B member 1 (ABCB1) proteins were sorted out from co-cultures according to a stringent multi-parameter gating strategy by fluorescence-activated cell sorting (FACS). The transfer rate of ABCB1 was measured by flow cytometry. The xenograft tumor models in mice were established to evaluate the transfer of ABCB1 in vivo. Gene expression was detected by real-time PCR and Western blotting. Results Herein, we show that a transient exposure to chemotherapeutic agents can strikingly increase Rab8B-mediated release of extracellular vesicles (EVs) containing ABCB1 from drug-resistant cells, and accelerate these EVs to circulate back onto plasma membrane of sensitive tumor cells via the down-regulation of Rab5. Therefore, intercellular ABCB1 transfer is significantly enhanced; sensitive recipient cells acquire a rapid but unsustainable resistance to evade the cytotoxicity of chemotherapeutic agents. More fascinatingly, in the xenograft tumor models, chemotherapeutical drugs also locally or distantly increase the transfer of ABCB1 molecules. Furthermore, some Non-small-cell lung carcinoma (NSCLC) patients who are undergoing primary chemotherapy have a rapid increase of ABCB1 protein in their monocytes, and this is obviously associated with poor chemotherapeutic efficacy. Conclusions Chemotherapeutic agents stimulate the secretion and recycling of ABCB1-enriched EVs through the dysregulation of Rab8B and Rab5, leading to a significant increase of ABCB1 intercellular transfer, thus assisting sensitive cancer cells to develop an urgent resistant phenotype. Our findings provide a new molecular mechanism of how chemotherapeutic drugs assist sensitive cancer cells in acquiring an urgent resistance.

Rab25-Mediated EGFR Recycling Causes Tumor Acquired Radioresistance.

Nimotuzumab Abrogates Acquired Radioresistance of KYSE-150R Esophageal Cancer Cells by Inhibiting EGFR Signaling and Cellular DNA Repair

Rab25 Promotes Erlotinib Resistance by Activating the Β1 Integrin/akt/β‐catenin Pathway in NSCLC

GPRC5A Suppresses Protein Synthesis at the Endoplasmic Reticulum to Prevent Radiation-Induced Lung Tumorigenesis

Rab5a suppresses autophagy to promote drug resistance in cancer cells

MiR–20a-5p Promotes Radio-Resistance by Targeting Rab27B in Nasopharyngeal Cancer Cells

RAB31 drives extracellular vesicle fusion and cancer-associated fibroblast formation leading to oxaliplatin resistance in colorectal cancer

RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer

Rab1A Promotes Cancer Metastasis and Radioresistance Through Activating GSK-3&#x3B2;/Wnt/&#x3B2;-catenin Signaling in Nasopharyngeal Carcinoma

Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion

Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response

Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance

Rab25 GTPase: Functional Roles in Cancer

Rab1A promotes cancer metastasis and radioresistance through activating GSK-3/Wnt/-catenin signaling in nasopharyngeal carcinoma

Deciphering colorectal cancer radioresistance and immune microrenvironment: unraveling the role of EIF5A through single-cell RNA sequencing and machine learning

EGFR and Radiosensitization of Tumor Cells

Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma.

Rab25 GTPase: Functional roles in cancer.

Rab25 Acts As an Oncogene and Participates in the Regulation of Aerobic Glycolysis Via PKM2 in Gastric Adenocarcinoma

Properties and Gene Expression Profiling of Acquired Radioresistance in Mouse Breast Cancer Cells.

Effect of EG00229 on Radiation Resistance of Lung Adenocarcinoma Cells.